Literature DB >> 26975995

Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions.

Elsje Pienaar1,2, William M Matern3, Jennifer J Linderman1, Joel S Bader4, Denise E Kirschner5.   

Abstract

Granulomas are a hallmark of tuberculosis. Inside granulomas, the pathogen Mycobacterium tuberculosis may enter a metabolically inactive state that is less susceptible to antibiotics. Understanding M. tuberculosis metabolism within granulomas could contribute to reducing the lengthy treatment required for tuberculosis and provide additional targets for new drugs. Two key adaptations of M. tuberculosis are a nonreplicating phenotype and accumulation of lipid inclusions in response to hypoxic conditions. To explore how these adaptations influence granuloma-scale outcomes in vivo, we present a multiscale in silico model of granuloma formation in tuberculosis. The model comprises host immunity, M. tuberculosis metabolism, M. tuberculosis growth adaptation to hypoxia, and nutrient diffusion. We calibrated our model to in vivo data from nonhuman primates and rabbits and apply the model to predict M. tuberculosis population dynamics and heterogeneity within granulomas. We found that bacterial populations are highly dynamic throughout infection in response to changing oxygen levels and host immunity pressures. Our results indicate that a nonreplicating phenotype, but not lipid inclusion formation, is important for long-term M. tuberculosis survival in granulomas. We used virtual M. tuberculosis knockouts to predict the impact of both metabolic enzyme inhibitors and metabolic pathways exploited to overcome inhibition. Results indicate that knockouts whose growth rates are below ∼66% of the wild-type growth rate in a culture medium featuring lipid as the only carbon source are unable to sustain infections in granulomas. By mapping metabolite- and gene-scale perturbations to granuloma-scale outcomes and predicting mechanisms of sterilization, our method provides a powerful tool for hypothesis testing and guiding experimental searches for novel antituberculosis interventions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26975995      PMCID: PMC4862722          DOI: 10.1128/IAI.01438-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  101 in total

Review 1.  A metabolic network approach for the identification and prioritization of antimicrobial drug targets.

Authors:  Arvind K Chavali; Kevin M D'Auria; Erik L Hewlett; Richard D Pearson; Jason A Papin
Journal:  Trends Microbiol       Date:  2012-01-31       Impact factor: 17.079

2.  Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism.

Authors:  D J V Beste; J Peters; T Hooper; C Avignone-Rossa; M E Bushell; J McFadden
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.

Authors:  Mohammad Fallahi-Sichani; JoAnne L Flynn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

4.  A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages.

Authors:  Gesham Magombedze; Nicola Mulder
Journal:  J Theor Biol       Date:  2011-09-29       Impact factor: 2.691

Review 5.  Advances in immunotherapy for tuberculosis treatment.

Authors:  Gavin J Churchyard; Gilla Kaplan; Dorothy Fallows; Robert S Wallis; Philip Onyebujoh; Graham A Rook
Journal:  Clin Chest Med       Date:  2009-12       Impact factor: 2.878

6.  IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Rachel A Kominsky; Gillian L Beamer; Paul Stromberg; Joanne Turner
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

Review 7.  New insights into TB physiology suggest untapped therapeutic opportunities.

Authors:  Christina E Baer; Eric J Rubin; Christopher M Sassetti
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

8.  A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy.

Authors:  Kevin Pethe; Patricia C Sequeira; Sanjay Agarwalla; Kyu Rhee; Kelli Kuhen; Wai Yee Phong; Viral Patel; David Beer; John R Walker; Jeyaraj Duraiswamy; Jan Jiricek; Thomas H Keller; Arnab Chatterjee; Mai Ping Tan; Manjunatha Ujjini; Srinivasa P S Rao; Luis Camacho; Pablo Bifani; Puiying A Mak; Ida Ma; S Whitney Barnes; Zhong Chen; David Plouffe; Pamela Thayalan; Seow Hwee Ng; Melvin Au; Boon Heng Lee; Bee Huat Tan; Sindhu Ravindran; Mahesh Nanjundappa; Xiuhua Lin; Anne Goh; Suresh B Lakshminarayana; Carolyn Shoen; Michael Cynamon; Barry Kreiswirth; Veronique Dartois; Eric C Peters; Richard Glynne; Sydney Brenner; Thomas Dick
Journal:  Nat Commun       Date:  2010-08-24       Impact factor: 14.919

9.  A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

Authors:  Chirajyoti Deb; Chang-Muk Lee; Vinod S Dubey; Jaiyanth Daniel; Bassam Abomoelak; Tatiana D Sirakova; Santosh Pawar; Linda Rogers; Pappachan E Kolattukudy
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

10.  Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection.

Authors:  Nicholas A Cilfone; Cory R Perry; Denise E Kirschner; Jennifer J Linderman
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

View more
  15 in total

1.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

Review 2.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

3.  Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model.

Authors:  Hayley C Warsinske; Elsje Pienaar; Jennifer J Linderman; Joshua T Mattila; Denise E Kirschner
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

4.  Modelling the effects of bacterial cell state and spatial location on tuberculosis treatment: Insights from a hybrid multiscale cellular automaton model.

Authors:  Ruth Bowness; Mark A J Chaplain; Gibin G Powathil; Stephen H Gillespie
Journal:  J Theor Biol       Date:  2018-03-07       Impact factor: 2.691

5.  Multifidelity Analysis for Predicting Rare Events in Stochastic Computational Models of Complex Biological Systems.

Authors:  Elsje Pienaar
Journal:  Biomed Eng Comput Biol       Date:  2018-08-03

6.  A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy.

Authors:  Qiyao Chai; Xudong Wang; Lihua Qiang; Yong Zhang; Pupu Ge; Zhe Lu; Yanzhao Zhong; Bingxi Li; Jing Wang; Lingqiang Zhang; Dawang Zhou; Wei Li; Wenzhu Dong; Yu Pang; George Fu Gao; Cui Hua Liu
Journal:  Nat Commun       Date:  2019-04-29       Impact factor: 14.919

7.  Spatial Lymphocyte Dynamics in Lymph Nodes Predicts the Cytotoxic T Cell Frequency Needed for HIV Infection Control.

Authors:  Dmitry Grebennikov; Anass Bouchnita; Vitaly Volpert; Nikolay Bessonov; Andreas Meyerhans; Gennady Bocharov
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

8.  Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.

Authors:  Elsje Pienaar; Jennifer J Linderman; Denise E Kirschner
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

Review 9.  Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases.

Authors:  Qiyao Chai; Yong Zhang; Cui Hua Liu
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

10.  Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas.

Authors:  Joseph M Cicchese; Véronique Dartois; Denise E Kirschner; Jennifer J Linderman
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.